How Bacteria Stick To Medical Implants And Cause Infection

Jenn Hoskins
21st August, 2025

How Bacteria Stick To Medical Implants And Cause Infection

Confocal laser scanning microscopy analysis demonstrates that while the dgcQ-deficient strain exhibits strong initial adhesion, elevated c-di-GMP levels are essential for maintaining the structural thickness and cell viability of mature Escherichia coli biofilms on PVC biomaterials (a–f).

Image adapted from: Li et al. / CC BY (Source)

Key Findings

  • Research from Kunming Medical University and the University of Pennsylvania shows that a molecule called c-di-GMP in E. coli dictates how well bacteria form protective biofilms on medical implants
  • High c-di-GMP levels allow bacteria to "hide" from the body's immune system, leading to persistent, hard-to-detect infections, while low levels trigger a stronger immune response
  • Targeting this c-di-GMP pathway could offer new ways to prevent or treat implant infections by disrupting biofilms or making bacteria more vulnerable to the immune system
Medical implants, such as hip and knee replacements, have significantly improved the quality of life for many patients. However, a persistent challenge is the risk of infection, which can lead to implant failure and necessitate painful and costly revision surgeries[2]. These infections are often difficult to treat because bacteria can form protective communities called biofilms on the implant surfaces. Biofilms shield bacteria from the body's immune system and make them highly resistant to antibiotics, contributing to a significant portion of healthcare-associated infections[3]. In fact, the presence of subclinical biofilms, meaning those not immediately obvious, can even lead to a misdiagnosis of aseptic loosening, where the implant failure is mistakenly attributed to non-infectious causes[2]. This highlights the urgent need for new strategies to combat these persistent infections. Recent research conducted by scientists at Kunming Medical University and the University of Pennsylvania has shed new light on how bacteria form these problematic biofilms, focusing on a crucial signaling molecule called cyclic di-GMP (c-di-GMP) in Escherichia coli (E. coli)[1]. E. coli is a common bacterium and a frequent cause of healthcare-associated infections, including those related to medical devices[3]. The study aimed to understand the precise role of c-di-GMP in infections associated with biomaterials, the materials used in medical implants. To investigate this, the researchers engineered four different E. coli strains, each with varying levels of c-di-GMP. One strain was a "knockout" (ΔdgcQ), meaning it had very low levels of c-di-GMP. Another was an "overexpression" strain (OdgcQ), designed to produce high levels of the molecule. A "complemented" strain (CΔdgcQ) was used to confirm the role of the specific gene, and a "wild-type" (WT) strain served as a normal comparison. Using various laboratory techniques, including crystal violet (CV) staining to measure biofilm mass, XTT assays to assess bacterial activity, and advanced microscopy like confocal laser scanning microscopy (CLSM) and scanning electron microscopy (SEM) to visualize the biofilm structures, the team observed distinct behaviors. They found that the strain with low c-di-GMP (ΔdgcQ) initially stuck more readily to the biomaterial surfaces. However, despite this initial strong adhesion, these bacteria struggled to form mature, robust biofilms. In contrast, strains with higher c-di-GMP levels (OdgcQ and CΔdgcQ) were highly effective at generating mature, well-established biofilms on the implant surfaces. The study also confirmed a known function of c-di-GMP: it reduces bacterial motility, or their ability to swim and move around. This is a key aspect of biofilm formation, as bacteria often slow down and settle to form these communities. Furthermore, high c-di-GMP levels enhanced the bacteria's ability to cope with environmental stresses, making them more resilient. Genetic analysis supported these observations, showing that genes responsible for motility were less active in high c-di-GMP strains, while genes involved in producing extracellular polymeric substances (EPS) – the sticky matrix that holds biofilms together – and genes for stress resistance were more active. Crucially, the researchers discovered a complex interplay between c-di-GMP levels and the bacteria's interaction with host cells and the immune system. The low c-di-GMP strain (ΔdgcQ) showed a greater tendency to adhere to and invade host cells, and it triggered a stronger immune response, characterized by the release of inflammatory signaling molecules like IL-1β and NF-κB. This suggests that bacteria with low c-di-GMP might be more "visible" to the body's defenses, potentially leading to a more acute, noticeable infection. Conversely, the high c-di-GMP strain (OdgcQ) exhibited a reduced ability to interact with host cells, showing decreased adhesion and invasion. More significantly, it inhibited the release of inflammatory cytokines, which are signaling proteins that coordinate the immune response. This finding is particularly important because it suggests that bacteria forming mature biofilms with high c-di-GMP can effectively "hide" from the immune system, leading to chronic infections that might not elicit a strong inflammatory signal. This aligns with previous findings that subclinical biofilms can be overlooked and lead to misdiagnosis of implant failures[2]. The ability of wear debris to inhibit the immune response, as noted in earlier studies[2], could further exacerbate this issue, allowing these "stealthy" high c-di-GMP biofilms to persist unchallenged. The interconnectivity of wear particle- and infection-associated mechanisms of implant loosening highlighted in earlier research[2] is further illuminated by these findings. The study from Kunming Medical University and the University of Pennsylvania suggests that the very mechanisms by which bacteria form protective biofilms (driven by c-di-GMP) also influence their interaction with the host immune system. If high c-di-GMP leads to reduced immune activation, it could contribute to the chronic inflammation and bone resorption seen in implant loosening without clear signs of acute infection. This research offers a promising new direction for combating implant-associated infections. Instead of solely relying on antibiotics, which face increasing challenges due to widespread antimicrobial resistance among common pathogens like E. coli[3], modulating the c-di-GMP signaling pathway could be a powerful strategy. By targeting this pathway, it might be possible to disrupt biofilm formation, make bacteria more susceptible to the body's immune response, or even render them more vulnerable to existing antimicrobial treatments. This approach could lead to novel biomaterials-based strategies to prevent and treat these complex infections, ultimately improving the long-term success of medical implants.

MedicineGeneticsBiochem

References

Main Study

1) The role of cyclic di-GMP in biomaterial-associated infections caused by commensal Escherichia coli

Published 20th August, 2025

https://doi.org/10.1371/journal.pone.0330229

Related Studies

2) Aseptic and septic prosthetic joint loosening: Impact of biomaterial wear on immune cell function, inflammation, and infection.

https://doi.org/10.1016/j.biomaterials.2021.121127

3) NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.

https://doi.org/10.1086/591861


Related Articles

An unhandled error has occurred. Reload 🗙